"What kind of "modernizations" should we expect to emerge from Health Canada's artfully stage-managed "technical consultations"? First and perhaps most important could be a shift of the burden of proof. The "precautionary principle" would be scrapped if drug companies had their way. So, instead of the drug industry having to prove that its products are (comparatively) safe before they can be licensed, new products would be presumed to be safe unless critics can prove that they are more harmful than beneficial."
No comments:
Post a Comment